A phase 1b double-blind, randomized, placebo-controlled, multicenter, dose titration study to evaluate the safety, tolerability, and pharmacokinetics of 4 weeks treatment with BAY 2413555 in participants with heart failure and implanted cardiac defib
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
May 10, 2022
End Date
December 31, 2023
Administered By
Duke Clinical Research Institute
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
May 10, 2022
End Date
December 31, 2023